Data di Pubblicazione:
2022
Abstract:
Background: Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative demyelinating
disease of the central nervous system. It is a complex and heterogeneous disease caused by a
combination of genetic and environmental factors, and it can cluster in families.
Objective: to evaluate at gene-level the aggregate contribution of predicted damaging low-frequency
and rare variants to MS risk in multiplex families
Methods: we performed whole exome sequencing (WES) in 28 multiplex MS families with at least 3
MS cases (81 affected and 42 unaffected relatives) and 38 unrelated healthy controls. A gene-based
burden test was then performed, focusing on two sets of candidate genes: i) literature-driven selection
and ii) data-driven selection.
Results: We identified 11 genes enriched with predicted damaging low-frequency and rare variants in
MS compared to healthy individuals. Among them, UBR2 and DST were the two genes with the
strongest enrichment (p=5×10-4 and 3×10-4, respectively); interestingly enough the association signal in UBR2 is driven by rs62414610, which was present in 25% of analysed families.
Conclusion: Despite limitations, this is one of the first studies evaluating the aggregate contribution of
predicted damaging low-frequency and rare variants in MS families using WES data. A replication
effort in independent cohorts is warranted to validate our findings and to evaluate the role of
identified genes in MS pathogenesis.
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
Multiple Sclerosis; family-based study; candidate gene; rare variants; burden test.
Elenco autori:
Liguori, Maria
Link alla scheda completa: